| Literature DB >> 30135785 |
Rony Kayrouz1, Blake F Dear1, Eyal Karin1, Milena Gandy1, Vincent J Fogliati1, Mathew D Terides1, Nickolai Titov1.
Abstract
This pilot study examined the efficacy and acceptability of a self-guided and culturally modified internet-delivered Cognitive Behaviour Therapy (iCBT) treatment for Arab people, aged 18 and over, with symptoms of depression and anxiety. Thirty-six participants from seven countries, with at least mild symptoms of depression (Patient Health Questionnaire 9-item; PHQ-9; total scores ≥ 5) or anxiety (Generalised Anxiety Disorder 7-item; GAD-7; total scores ≥ 5) accessed the online Arabic Wellbeing Course, which consisted of five online lessons delivered over eight weeks and presented in the English language. Standard measures of depression, anxiety, distress and disability were administered at pre-treatment, post-treatment and 3-month follow-up. Thirty-six percent of participants completed the five lessons over eight weeks, with 61% and 36% providing post-treatment and 3-month follow-up data respectively. Participants reported significant improvements (within-group Cohen's d; avg. reduction) in depression (ds ≥ 1.20; avg. reduction ≥ 46%), anxiety (ds ≥ 1.15; avg. reduction ≥ 45%), disability (ds ≥ 0.81; avg. reduction ≥ 35%) and psychological distress (ds ≥ 0.91; avg. reduction ≥ 24%) immediately post-treatment, which were sustained at or further improved to 3-month follow-up. Participants rated the Arabic Wellbeing Course as acceptable. Notwithstanding the absence of a control group, low follow-up questionnaire completion rates and the Course not being translated in Arabic, these results are encouraging and contribute to a growing body of literature indicating that, with minor modifications, internet-delivered interventions have the potential of increasing access to treatment for immigrant groups.Entities:
Keywords: Anxiety; Arabs; Depression; Internet-delivered treatment; Transdiagnostic
Year: 2015 PMID: 30135785 PMCID: PMC6096118 DOI: 10.1016/j.invent.2015.10.005
Source DB: PubMed Journal: Internet Interv ISSN: 2214-7829
Fig. 1Participant flow.
Observed and estimated means, standard deviations, confidence intervals effect sizes (Cohen's d) and percentage change for the overall sample.
| Observed means | Estimated marginal means | LOCF means | Cohen's d effect sizes | Percentage change from baseline | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Follow-up | Pre | Post | Follow-up | Pre | Post | Follow-up | Pre to post | Post to follow-up | Pre to post | Pre to follow-up | |
| Depression (PHQ-9) | 12.08 (4.87) | 6.54 (5.91) | 4.08 (4.54) | 12.08 (4.80) | 6.49 (4.51) | 4.37 (2.62) | 12.08 (4.87) | 8.39 (5.91) | 7.72 (5.64) | 1.20 (.69–1.69) | .57 (.10–1.04) | 46.3 (32.6–57.2) | 63.8 (56.0–70.3) |
| Anxiety (GAD-7) | 10.44 (4.01) | 5.77 (5.59) | 3.77 (5.02) | 10.44 (3.96) | 5.72 (4.27) | 4.58 (2.96) | 10.44 (4.01) | 7.61 (5.54) | 7.31 (5.54) | 1.15 (.64–1.63) | .31 (−.16–0.77) | 45.3 (30.2–57.1) | 56.2 (45.9–64.5) |
| Disability (SDS) | 22.50 (9.89) | 14.77 (13.10) | 9.08 (13.51) | 22.50 (9.75) | 14.54 (10.01) | 8.99 (7.80) | 22.50 (9.89) | – | – | 0.81 (.32–1.28) | .62 (.14–1.08) | 35.4 (19.1–48.4) | 60.0 (46.9–69.9) |
| Distress (K10) | 28.06 (6.96) | 21.13 (10.85) | 17.23 (9.09) | 28.06 (6.86) | 21.11 (8.29) | 17.88 (5.27) | 28.06 (6.96) | – | – | 0.91 (.42–1.39) | .47 (−.01–.93) | 24.8 (14.5–33.8) | 36.3 (29.8–42.1) |
Note. Standard deviations and 95% confidence intervals are shown in parentheses. Pre: Pre-treatment, Post: Post-treatment; Follow-up: 3 month follow-up; PHQ-9: Patient Health Questionnaire 9-Item; GAD-7: Generalised Anxiety Disorder 7-Item.; SDS: Sheehan Disability Scale; K10: Kessler 10-item; LOCF: Last Observation Carried Forward. No LOCF for secondary measures as no mid-treatment data was collected.
The effect sizes from baseline statistics are based on estimated marginal means derived from the GEE models.
The percentage change from baseline statistics are estimates of relative change derived from the GEE models conducted separately for each outcome.
Proportion of participants below cut-off scores of clinical significance (remission) and proportion demonstrating at least 50% reduction in pre-treatment scores (recovery) and the average improvement of the group.
| Pre-treatment | Post-treatment | 3-month follow-up | |||||
|---|---|---|---|---|---|---|---|
| ≥ Clinical cut-off | ≤ Clinical cut-off | ≥ 50% improvement | Average improvement | ≤ Clinical cut-off | ≥ 50% improvement | Average improvement | |
| PHQ-9 | 24/36 (66.67%) | 11/24 (45.83%) | 11/36 (30.55%) | 27.05% | 11/24 (45.83%) | 15/36 (41.67%) | 34.09% |
| GAD-7 | 23/36 (63.90%) | 10/23 (43.48%) | 13/36 (36.11%) | 27.24% | 10/23 (43.48%) | 13/36 (36.11%) | 31.42% |
Note. Intention-to-treat model was employed with last-observation being carried forward if follow-up data was not available. The clinical cut-off utilised for the PHQ-9 and GAD-7 was 10 and 8 respectively.